Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Jubilant Pharmova: Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws And To Approve Seeking Shareholders'' Approval As May Be Required
News Announcement

Jubilant Pharmova: Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws And To Approve Seeking Shareholders'' Approval As May Be Required

07-Oct-2026 Follow Value Research Online on Google download pdfDownload PDF Jubilant Pharmova

Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 inter alia to consider and approve To consider and approve raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws and to approve seeking shareholders approval as may be required

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month